Impact of extended interval dosing of immune checkpoint inhibitors in lung cancer patients during the COVID-19 pandemic.
Respiratory medicine and research（2023）
摘要
Our study suggests that EI dosing of ICIs did not affect toxicity and overall survival in lung cancer patients.
更多查看译文
关键词
COVID 19-pandemic,Immune checkpoint inhibitors,Immune-related toxicity,Lung cancer
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要